PlainPharmaWatch

CMS Open Payments · Tool

Steris Corporation vs Novartis Pharma AG

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Steris Corporation has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,847, versus 557 for the other company. Its single largest recorded recipient represents 0.5% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Steris Corporation
HHI 2,847 · top recipient 0.5%
Ranked #591 of 1,838 companies by HHI
Novartis Pharma AG
HHI 557 · top recipient 0.1%
Ranked #1,251 of 1,838 companies by HHI

Payment Overview

Company A

Steris Corporation

Total Payments
$514.3K
% of Industry
0.0%
Transactions
783
Avg per Transaction
$656.78
Recipients
783
Avg per Recipient
$656.78
Payment Types
9
Top Payment Type
Charitable Contribution
Company B

Novartis Pharma AG

Total Payments
$513.5K
% of Industry
0.0%
Transactions
259
Avg per Transaction
$2.0K
Recipients
73
Avg per Recipient
$7.0K
Payment Types
4
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Steris Corporation vs Novartis Pharma AG - total reported payments in CMS Open Payments PY2024

Steris Corporation$514.3KNovartis Pharma AG$513.5K

Payment Types Breakdown

Steris Corporation

Charitable Contribution $218.3K

42.4%

Consulting Fee $85.5K

16.6%

Travel and Lodging $68.0K

13.2%

Royalty or License $64.0K

12.5%

Food and Beverage $61.1K

11.9%

Space Rental or Facility Fees $11.9K

2.3%

Novartis Pharma AG

Consulting Fee $141.9K

27.6%

Travel and Lodging $16.7K

3.2%

Education $2.9K

0.6%

Food and Beverage $432.70

0.1%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Steris Corporation

  1. 1

    Uh Cleveland Medical Center

    $268,500.00 · 13 txns

  2. 2

    ALBERT RHOTON

    $47,284.75 · 2 txns

  3. 3

    Adventhealth Orlando

    $22,700.00 · 4 txns

  4. 4

    Cleveland Clinic Hospital

    $8,904.32 · 2 txns

  5. 5

    TOUFIC KACHAAMY

    $6,978.48 · 26 txns

Novartis Pharma AG

  1. 1

    R WRIGHT

    $22,164.28 · 8 txns

  2. 2

    DEJAN JURIC

    $15,648.68 · 5 txns

  3. 3

    BIPIN SAVANI

    $15,600.00 · 2 txns

  4. 4

    AMIT BAR-OR

    $9,115.94 · 4 txns

  5. 5

    JORGE E CORTES-FRANCO

    $8,568.77 · 7 txns

Summary Comparison

Metric Steris Corporation Novartis Pharma AG
Total Payments $514.3K $513.5K
% of Industry Total 0.0% 0.0%
Transaction Count 783 259
Avg per Transaction $656.78 $2.0K
Recipient Count 783 73
Avg per Recipient $656.78 $7.0K
Payment Type Count 9 4
Top Payment Type Charitable Contribution Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.